Literature DB >> 27743739

15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage.

Jubilee Brown1, R Wendel Naumann2, Michael J Seckl3, Julian Schink4.   

Abstract

Significant improvements in treatment and the understanding of gestational trophoblastic neoplasia have occurred in the last 15years. These diseases are almost always curable, and refractory patients have more options for salvage therapy. Recent improvements in the understanding of epidemiology, diagnosis, and cell biology have resulted in changes in staging, advances in treatment options, and opportunities for fertility preservation.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Choriocarcinoma; Gestational trophoblastic disease; Hydatidiform mole; Placental site trophoblastic tumor

Mesh：

Year:  2016        PMID： 27743739     DOI： 10.1016/j.ygyno.2016.08.330

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


  24 in total

1.  Fatal cervix rupture due to intraplacental choriocarcinoma triggered by sexual intercourse.

Authors:  Huang Weisheng; Wu Shuang; Liang Yue; Tong Fang; Dong Hongmei; Zhou Yiwu
Journal:  Int J Legal Med       Date:  2019-11-07       Impact factor: 2.686

2.  Cost-effectiveness of second curettage for treatment of low-risk non-metastatic gestational trophoblastic neoplasia.

Authors:  Samantha Batman; Ashley Skeith; Allison Allen; Elizabeth Munro; Aaron Caughey; Amanda Bruegl
Journal:  Gynecol Oncol       Date:  2020-04-08       Impact factor: 5.482

3.  Successful detection of SRY gene via fine needle biopsy: A case of extragenital gestational choriocarcinoma in the kidney.

Authors:  Shunsuke Orisaka; Kyosuke Kagami; Yasunari Mizumoto; Wataru Koda; Masanori Ono; Mitsuhiro Nakamura; Hiroshi Fujiwara
Journal:  Mol Clin Oncol       Date:  2017-10-18

4.  Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia.

Authors:  Mingliang Ji; Shiyang Jiang; Jun Zhao; Xirun Wan; Fengzhi Feng; Tong Ren; Junjun Yang; Yang Xiang
Journal:  Br J Cancer       Date:  2022-04-22       Impact factor: 9.075

Review 5.  Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine.

Authors:  Natalia Buza; Pei Hui
Journal:  Mod Pathol       Date:  2021-06-04       Impact factor: 7.842

6.  High Incidence of Gestational Trophoblastic Disease in a Third-Level University-Hospital, Italy: A Retrospective Cohort Study.

Authors:  Giampiero Capobianco; Elettra Tinacci; Laura Saderi; Francesco Dessole; Marco Petrillo; Massimo Madonia; Giuseppe Virdis; Alessandro Olivari; Davide Adriano Santeufemia; Antonio Cossu; Salvatore Dessole; Giovanni Sotgiu; Pier Luigi Cherchi
Journal:  Front Oncol       Date:  2021-05-05       Impact factor: 6.244

7.  SEOM clinical guidelines in gestational trophoblastic disease (2017).

Authors:  A Santaballa; Y García; A Herrero; N Laínez; J Fuentes; A De Juan; V Rodriguez Freixinós; J Aparicio; A Casado; E García-Martinez
Journal:  Clin Transl Oncol       Date:  2017-11-17       Impact factor: 3.405

Review 8.  A rational diagnostic approach to the "phantom hCG" and other clinical scenarios in which a patient is thought to be pregnant but is not.

Authors:  Oluwafunmilayo Oyatogun; Mandeep Sandhu; Stephanie Barata-Kirby; Erin Tuller; Danny J Schust
Journal:  Ther Adv Reprod Health       Date:  2021-06-13

9.  Risk Factors for Hydatidiform Mole: Is Husband’s Job a Major Risk Factor?

Authors:  Hourieh Shamshiri Milani; Morteza Abdollahi; Sara Torbati; Taha Asbaghi; Eznollah Azargashb
Journal:  Asian Pac J Cancer Prev       Date:  2017-10-26

10.  A metastatic invasive mole arising from iatrogenic uterus perforation.

Authors:  Yuanming Shen; Xiaoyun Wan; Xing Xie
Journal:  BMC Cancer       Date:  2017-12-20       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.